Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenvue, Inc. (KVUE)
NYSE:KVUE
Holding KVUE?
Track your performance easily
KVUE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.67 - $24.46
Previous CloseN/A
Volume2.33M
Average Volume (3M)11.15M
Market Cap
$40.63B
Enterprise Value$52.52B
Total Cash (Recent Filing)$1.38B
Total Debt (Recent Filing)$7.69B
Price to Earnings (P/E)38.2
Beta0.49
Next Earnings
Feb 06, 2025EPS Estimate
0.26Next Dividend Ex-Date
Feb 12, 2025Dividend Yield3.82%
Share Statistics
EPS (TTM)0.55
Shares Outstanding1,917,257,400
10 Day Avg. Volume9,436,866
30 Day Avg. Volume11,145,922
Standard Deviation0.09
R-Squared0.36
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.63
Price to Cash Flow (P/CF)40.80
P/FCF Ratio38.80
Enterprise Value/Market Cap1.29
Enterprise Value/Revenue3.40
Enterprise Value/Gross Profit6.08
Enterprise Value/Ebitda20.32
Forecast
1Y Price Target
$23.86Price Target Upside13.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Kenvue, Inc. News
Bulls Say, Bears Say
Bulls Say
Brand PerformanceRecent trends suggest the brand is starting to regain its footing in the US.
Growth StrategyManagement's long-term growth strategy of sales and bottom-line growth, coupled with a solid dividend yield, is expected to yield solid stock returns.
Operational StrategyThe separation from Johnson & Johnson has allowed Kenvue to have more flexibility in making decisions to drive more profitable growth.
Bears Say
Management And Strategic ExecutionMissteps in strategy and execution post-split from Johnson & Johnson suggest potential management and board changes may be necessary.
Market Share And Brand PerformancePost-IPO, KVUE's brands, particularly in the skin health and beauty segment, have underperformed due to market share challenges.
Sales PerformanceSales were slightly below estimates, with a decline in the SH&B segment due to a weak sun season and decelerating skincare category.
---
Ownership Overview
0.02% Insiders
36.70% Mutual Funds
0.41% Other Institutional Investors
37.46% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $17.67 and its highest was $24.46 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Kenvue, Inc.’s market cap is $40.63B.
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Feb 06, 2025 which is in 19 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on Nov 07, 2024. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.272 by $0.008.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Semiannually dividend of $0.808 which represents an annual dividend yield of 3.82%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is 0.26.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,917,257,400 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.28 in its last earnings report, beating expectations of $0.272. Following the earnings report the stock price went up 2.108%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Among the largest hedge funds holding Kenvue, Inc.’s share is Yacktman Asset Management LP. It holds Kenvue, Inc.’s shares valued at 194M.
---
Kenvue, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$23.86 (13.08% Upside)
$23.86 (13.08% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 83%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 770.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.4%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.59%
12-Months-Change
Fundamentals
Return on Equity
9.88%
Trailing 12-Months
Asset Growth
-0.56%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue Inc is a pure-play consumer health company. It is a global leader at the intersection of healthcare and consumer goods, with a portfolio of iconic brands, operating in some of the most attractive categories in consumer health. The consumer health portfolio includes self-care, skincare and beauty and essential personal care products.
---
KVUE Company Deck
---
KVUE Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a balanced performance with significant achievements in operational efficiencies and certain segments like Essential Health, but also challenges in Skin Health and Beauty and a softer top line growth projection. The transformation efforts and strategic investments in marketing and infrastructure are promising, but the external market conditions and specific segment underperformance present notable challenges.Read More>---
KVUE Revenue Breakdown
41.77% Self Care
29.88% Essential Health
28.35% Skin Health and Beauty
---
KVUE Stock 12 Month Forecast
Average Price Target
$23.86
▲(13.08% Upside)
Technical Analysis
Best Analysts Covering KVUE
1 Year
1 Year Success Rate
8/10 ratings generated profit
1 Year Average Return
+7.92%
reiterated a buy rating 3 months ago
Copying Andrea Faria Teixeira's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +7.92% per trade.
---